0.66
전일 마감가:
$0.687
열려 있는:
$0.6897
하루 거래량:
419.46K
Relative Volume:
1.03
시가총액:
$27.67M
수익:
$3.26M
순이익/손실:
$-19.52M
주가수익비율:
-1.65
EPS:
-0.4
순현금흐름:
$-24.10M
1주 성능:
-14.29%
1개월 성능:
-14.29%
6개월 성능:
-33.19%
1년 성능:
-51.47%
Scynexis Inc Stock (SCYX) Company Profile
명칭
Scynexis Inc
전화
201-884-5485
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
SCYX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SCYX
Scynexis Inc
|
0.66 | 28.80M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-22 | 개시 | Guggenheim | Buy |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-07-11 | 업그레이드 | Needham | Hold → Buy |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2017-07-10 | 개시 | ROTH Capital | Buy |
| 2017-05-09 | 다운그레이드 | Needham | Buy → Hold |
| 2017-03-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-20 | 개시 | H.C. Wainwright | Buy |
| 2016-10-07 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | 재개 | Brean Capital | Buy |
| 2016-08-17 | 개시 | Guggenheim | Buy |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-08-09 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | 개시 | Brean Capital | Buy |
| 2015-12-29 | 개시 | WBB Securities | Speculative Buy |
| 2015-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-06-10 | 개시 | Needham | Buy |
| 2014-05-29 | 개시 | Canaccord Genuity | Buy |
| 2014-05-29 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Scynexis Inc 주식(SCYX)의 최신 뉴스
Can SCYNEXIS Inc. stock maintain growth trajectoryQuarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
How supply chain issues affect SCYNEXIS Inc. stockJuly 2025 Retail & Weekly Momentum Picks - newser.com
How to build a dashboard for SCYNEXIS Inc. stockExit Point & Expert Approved Momentum Ideas - newser.com
Is SCYNEXIS Inc. stock bottoming outMarket Sentiment Report & Daily Profit Focused Screening - newser.com
Will SCYNEXIS Inc. stock recover faster than peersInsider Buying & Weekly Market Pulse Alerts - newser.com
Should I hold or sell SCYNEXIS Inc. stock in 20252025 Market Sentiment & Free Technical Confirmation Trade Alerts - newser.com
Live market analysis of SCYNEXIS Inc.2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
SCYNEXIS Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
How interest rate cuts could boost SCYNEXIS Inc. stockJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
How SCYNEXIS Inc. (135A) stock performs in volatility spikes2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why SCYNEXIS Inc. (135A) stock stays resilient2025 Retail Activity & Real-Time Volume Triggers - newser.com
Will SCYNEXIS Inc. continue its uptrendJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Is SCYNEXIS Inc. stock ready for a breakout2025 Performance Recap & Weekly High Momentum Picks - newser.com
Why SCYNEXIS Inc. (135A) stock benefits from AI revolution2025 Key Lessons & Growth Focused Entry Reports - newser.com
How geopolitical tensions affect SCYNEXIS Inc. stock2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Analyzing recovery setups for SCYNEXIS Inc. investorsJuly 2025 Market Mood & Reliable Entry Point Alerts - newser.com
Guggenheim Lowers Price Target for SCYNEXIS (SCYX) but Maintains Buy Rating | SCYX Stock News - GuruFocus
Guggenheim lowers SCYNEXIS stock price target to $3 after GSK trial resolution - Investing.com
SCYNEXIS Inc. stock daily chart insightsJuly 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Scynexis Inc (SCYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):